Alpha 2.0
Login Register
» Authors » Afshin Amirpour

Afshin Amirpour

Explore the profile of Afshin Amirpour including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 56
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Biomedical Engineering
General Medicine
Top 10 Co-Authors
Reihaneh Zavar
Masoumeh Sadeghi
Javad Shahabi
Pejman Mansouri
Hamid Sanei
Mohammad Hadi Mansouri
Alireza Khosravi
Hamidreza Roohafza
Seyedeh Mahnaz Mirbod
Nizal Sarrafzadegan
Published In
ARYA Atheroscler
Adv Biomed Res
J Res Med Sci
Curr Probl Cardiol
Thromb J
Affiliations
Soon will be listed here.
Recent Articles
1.
Comparing the Effect of Moderate-Intensity Versus High-Intensity Interval Training Exercise on Global Longitudinal Strain (GLS) in Cardiovascular Patients: Systematic Review and Meta-Analysis
Ghazavi S, Zavar R, Sadeghi M, Amirpour A, Amerizadeh A
Cardiol Res Pract . 2025 Feb; 2025:9901472. PMID: 39963426
Left ventricular global longitudinal strain (LVGLS) is a highly sensitive echocardiographic biomarker that detects signs of myocardial dysfunction. It has been proven that exercise-based cardiac rehabilitation (CR) improves LV-GLS but...
2.
Association between ST-segment changes in lead aVR and angiographic findings, syntax score, short-term and intermediate outcomes in patients with acute coronary syndrome: A pilot study
Amirpour A, Masoumi H, Sadeghi M, Zavar R, Darouei B, Mirbod S, et al.
ARYA Atheroscler . 2024 Dec; 20(5):25-37. PMID: 39717162
Background: In this study, we aimed to investigate the prognostic implications of lead aVR ST-segment elevation in an initial electrocardiogram (ECG) in patients diagnosed with acute coronary syndrome (ACS). Furthermore,...
3.
The Effect of Vitamin D Deficiency Treatment on Lipid Profile and C-reactive Protein in Patients with Ischemic Heart Disease: Double-blind Randomized Clinical Trial
Sadeghi M, Momeni A, Mirsaeidi F, Jamalian M, Amirpour A, Hadavi M, et al.
Adv Biomed Res . 2024 Nov; 13:79. PMID: 39512413
Background: Atherosclerosis is the main process in coronary artery stenosis, which is exacerbated by vitamin D deficiency. This study aims to investigate the relationship between vitamin D deficiency treatment, lipid...
4.
Compare efficacy and safety of autologous blood clot injection with C-clamp vascular closure device in treatment of iatrogenic pseudoaneurysm after femoral artery puncture
Mansouri M, Mansouri P, Hashemi M, Hashemi S, Mirshafiee S, Amirpour A
J Vasc Access . 2024 Aug; :11297298241273641. PMID: 39180356
Introduction: Iatrogenic femoral artery pseudoaneurysm (FAP) is a complication following femoral artery puncture, with an incidence rate of 0.2%-5.5% post-cardiac catheterization procedures. Management typically involves observation or interventional treatments such...
5.
The assessment of no-reflow phenomenon incidence in early versus delayed percutaneous coronary intervention following a primary fibrinolysis
Amirpour A, Behjati M, Zavar R, Shirvani E, Zarepour E, Hassannejad R, et al.
ARYA Atheroscler . 2024 Aug; 20(2):31-40. PMID: 39170814
Background: Percutaneous coronary intervention (PCI) is the gold standard approach to ST-Segment Elevation Myocardial Infarction (STEMI). Fibrinolysis followed by PCI has been recommended. The current study aims to investigate the...
6.
Intramyocardial dissecting hematoma: A systematic review and pooled analysis of available literature
Zavar R, Soleimani A, Tajmirriahi M, Amirpour A, Mahmoudiandehcordi S, Farhang F
ARYA Atheroscler . 2024 Aug; 20(1):62-71. PMID: 39165850
Background: The current systematic review and pooled analysis were conducted to answer several questions using findings from case reports and case series as follows: (1) Demographic characteristics; (2) clinical findings;...
7.
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial
Mansouri P, Jazi Z, Mansouri M, Dehghan H, Zavar R, Hashemi S, et al.
Thromb J . 2024 Jul; 22(1):66. PMID: 39030573
Introduction: This research is one of the pioneering randomized clinical trials (RCTs) aimed at assessing the effectiveness and safety of rivaroxaban in treating left ventricular thrombus (LVT) in patients who...
8.
Anticoagulant and antiplatelet treatment effects on the incidence of major cardiovascular events in patients with coronary artery ectasia: An updated systematic review
Amirpour A, Zavar R, Danesh M, Mirbod S, Zaker E, Moslemi F, et al.
Indian Heart J . 2024 Jul; 76(4):247-253. PMID: 39009077
Introduction: Coronary artery ectasia (CAE), widenings in sections of the arteries, is a rare condition found in up to 3-5% of angiography cases. Sometimes recurrence of major adverse cardiac events...
9.
Apixaban, a Novel Oral Anticoagulant, Use to Resolute Arterial Patency in Radial Artery Occlusion Due to Cardiac Catheterization; A Pilot Randomized Clinical Trial
Amirpour A, Zavar R, Seifipour A, Sadeghi M, Shirvani E, Kermani-Alghoraishi M, et al.
ARYA Atheroscler . 2024 Jun; 19(6):18-26. PMID: 38883851
Introduction: In recent years, transradial cardiac catheterization has become the preferred method. However, it can result in a significant complication known as radial artery occlusion (RAO). The medical management of...
10.
Fibrinolytic Therapy in Thrombosis of Mechanical Valves: Outcomes and Complications
Nasri Nasrabadi A, Yarahmadi F, Amirpour A, Zavar R, Akbari M
ARYA Atheroscler . 2024 Jun; 19(5):18-24. PMID: 38882648
Introduction: Valvular heart disease presents a significant and escalating global health challenge. Prosthetic valve thrombosis (PVT) following surgical valve replacement is a primary cause of valve failure. The aim of...